1. Clinical studies using heckel WBH systems

Schmidt R:
Studie zur ambulanten moderaten Ganzkörperhyperthermie bei Fibromyalgiesyndrom (Vorstellung des Studiendesigns)
[ARTICLE IN GERMAN] Erfahrungsheilkunde 2022; 71(03): 158-165; DOI: 10.1055/a-1789-2165
https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1789-2165

Romeyke T, Stummer H:
Multi-Modal Pain Therapy of Fibromyalgia Syndrome with Integration of Systemic Whole-Body Hyperthermia – Effects on Pain Intensity and Mental State: A Non-Randomised Controlled Study
Journal of Musculoskeletal Pain Vol: 22, Issue 4, December 2014, pages 341-355
http://www.tandfonline.com/doi/full/10.3109/10582452.2014.949336

Romeyke T, Scheuer HC, Stummer H:
Fibromyalgia with severe forms of progression in a multidisciplinary therapy setting with emphasis on hyperthermia therapy--a prospective controlled study    
Clin Interv Aging. 2014 Dec
OPEN ACCESS https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279606/

2. Clinical studies using other WBH systems

Brockow T, Wagner A, Franke A, Offenbächer M, Resch KL:
A randomized controlled trial on the effectiveness of mild water-filtered near infrared whole-body hyperthermia as an adjunct to a standard multimodal rehabilitation in the treatment of fibromyalgia.
Clin J Pain. 2007 Jan;23(1):67-75
https://www.ncbi.nlm.nih.gov/pubmed/17277647

3. Clinical case reports using heckel WBH systems

Winnicki C, Hanusch KU:
Hyperthermie gegen Fibromyalgiesyndrom
Schweiz Z Ganzheitsmed 2013;25:267-268
[ARTICLE IN GERMAN] OPEN ACCESS https://www.karger.com/Article/FullText/355025

4. Others

Häuser W, Jung E, Erbslöh-Möller B,Gesmann M, Kühn-Becker H,Petermann F, Langhorst J, Thoma R, Weiss T, Wolfe F, Winkelmann A:
The German fibromyalgia consumer reports – a cross-sectional survey
BMC Musculoskelet Disord. 2012; 13: 74
OPEN ACCESS https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444387/

5. Congress abstracts

Romeyke T:
Systemic whole-body hyperthermia: a therapy option for the treatment of fibromyalgia?
The 4th International Virtual Congress on Controversies in Fibromyalgia - Poster Presentations - P14, page 20
Clinical and Experimental Rheumatology 2022
https://www.clinexprheumatol.org/article.asp?a=18767

1. Clinical studies using heckel WBH systems

Moghaddam FF, Bakhshandeh M, Mofid B, Sahinbas H, Faeghi F, Mirzael H, Rakhsha A, Kashi ASY, Sadeghi R, Mahdavi:
Clinical effectiveness of combined whole body hyperthermia and external beam radiation therapy (EBRT) versus EBRT alone in patients with painful bony metastases: A phase III clinical trial study.
J Therm Biol. 2024 Feb:120:103804. DOI 10.1016/j.jtherbio.2024.103804
https://pubmed.ncbi.nlm.nih.gov/38460451/

Zschaeck S, Weingärtner J, Ghadjar P, Wust P, Mehrhof F, Kalinauskaite G, Ehrhardt VH, Hartmann V, Tinhofer I, Heiland M, Coordes A, Kofla G, Budach V, Stromberger C, Beck M:
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective study    
Oral Oncol. 2021 Feb 21;116:105240. Online ahead of print.
https://pubmed.ncbi.nlm.nih.gov/33626457/

Rogasch J, Beck M, Stromberger C, Hofheinz F, Ghadjar P, Wust P, Budach V, Amthauer H, Tinhofer I, Furth C, Walter-Rittel TC, Zschaeck S:
PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study
F1000Res. 2020 Nov 19;9:1350
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970429/

Kleef R, Nagy R, Baierl A, Bacher V, Bojar H, McKee DL, Moss R, Thoennissen NH, Szász M, Bakacs T
Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers - a retrospective study of a single institution    
Cancer Immunol Immunother. 2020
OPEN ACCESS: https://link.springer.com/article/10.1007/s00262-020-02751-0

Kobayashi Y, Itoa Y, Ostapenko VV, Sakai M, Matsushita N, Imai K, Shimizu K, Aruga A,Tanigawa K:
Fever-range whole-body heat treatment stimulates antigen-specificT-cell responses in humans
Immunology Letters 162 (2014) 256–261
https://www.ncbi.nlm.nih.gov/pubmed/25256774

Sulyok I, Fleischmann E, Stift A, Roth G, Lebherz-Eichinger D, Kasper D, Spittler A, Kimberger O:
Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery
Br J Anaesth. 2012 Nov;109(5):754-61
OPEN ACCESS https://academic.oup.com/bja/article/109/5/754/305182/Effect-of-preoperative-fever-range-whole-body

Bull JM, Scott GL, Strebel FR, Nagle VL, Oliver D, Redwine M, Rowe RW, Ahn CW, Koch SM:
Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol.
Int J Hyperthermia. 2008 Dec;24(8):649-62
https://www.ncbi.nlm.nih.gov/pubmed/18608594

Kraybill WG, Olenki T, Evans SS, Ostberg JR, O'Leary KA, Gibbs JF, Repasky EA:
A phase I study of fever-range whole body hyperthermia (FR-WBH) in patients with advanced solid tumours: correlation with mouse models.
Int J Hyperthermia. 2002 May-Jun;18(3):253-66
https://www.ncbi.nlm.nih.gov/pubmed/12028640

2. Clinical case reports using heckel WBH systems

Kleef R, Bacher V, Nagy R, Reisegger P, Bakacs T:
Complete Remission of Vocal Cord Cancer Treated With Low-Dose Ipilimumab Plus Nivolumab Combined With Interleukin-2 and Hyperthermia
Cureus. 2021 Apr 15;13(4):e14500. doi: 10.7759/cureus.14500.
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123238/

Kleef R, Moss R, Szasz AM, Bohdjalian A, Bojar H, Bakacs T:
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2
Integr Cancer Ther. 2018 Dec; 17(4): 1297–1303.
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247552/

Rich LJ, Winslow TB, Alberico RA, Repasky EA, Seshadri M, Singh AK:
Enhanced tumour perfusion following treatment with water-filtered IR-A radiation to the thorax in a patient with head and neck cancer.
Int J Hyperthermia. 2016 Aug;32(5):539-42, LETTER TO THE EDITOR
https://www.ncbi.nlm.nih.gov/pubmed/27150820

Kleef R, Kekic S, Ludwig N:
Successful Treatment of Advanced Ovarian Cancer with Thermochemotherapy and Adjuvant Immune Therapy
Case Rep Oncol 2012;5:212–215
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369243/

3. Pre-clinical studies

Rowe RW, Strebel FR, Proett JM, Deng W, Chan D, He G, Siddik ZH, Bull JMC:
Fever-Range Whole-body Thermotherapy Combined With Oxaliplatin: A Curative Regimen in a Preclinical Breast Cancer Model
Int J Hyperthermia. 2010; 26(6): 565–576
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045248/

4. Reviews

Bull JMC:
A review of immune therapy in cancer and a question: can thermal therapy increase tumor response?
Int J Hyperthermia. 2018 Sep;34(6):840-852.
OPEN ACCESS: https://www.tandfonline.com/doi/pdf/10.1080/02656736.2017.1387938?needAccess=true

Yagawa Y, Tanigawa K, Kobayashi Y, Yamamoto M:
Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery.
J Cancer Metastasis Treat 2017;3:218-30
OPEN ACCESS: http://jcmtjournal.com/article/view/2272

Repasky EA, Evans SS, Dewhirst M:
Temperature Matters! And Why it Should Matter to Tumor Immunologists.
Cancer Immunol Res. 2013 Oct 1; 1(4)
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904378/

Faghihi Moghadam F, Bakhshandeh M, Sahinbas H:
Hyperthermia: A Neoadjuvant Therapeutic Approach in Cancer Treatment
CANCERPRESS Vol. 3, No.1, March, 2017
OPEN ACCESS: https://www.semanticscholar.org/paper/Hyperthermia%3A-A-Neoadjuvant-Therapeutic-Approach-in-Moghadam-Bakhshandeh/bddde59d4cf9518d10b83029b7ec29ab895d75e7

5. Books, book chapters

Zschaeck S, Beck M:
Whole-Body Hyperthermia in Oncology: Renaissance in the Immunotherapy Era?
In: Water-filtered Infrared A (wIRA) Irradiation (Ed.: P. Vaupel), pp. 107-115. Springer Nature Switzerland, Cham. DOI: 10.1007/978-3-030-92880-3_8
OPEN ACCESS https://link.springer.com/content/pdf/10.1007%2F978-3-030-92880-3_8

Tanigawa K, Ito Y, Kobayashi Y:
Effects of Fever-Range Hyperthermia on T Cell-Mediated Immunity: Possible Combination of Hyperthermia and T Cell-Based Cancer Immunotherapy
in: S. Kokura et al. (eds.), Hyperthermic Oncology from Bench to Bedside, Springer Science+Business Media Singapore 2016
https://link.springer.com/chapter/10.1007/978-981-10-0719-4_31

Rowe-Horwege W:
Hyperthermia, Systemic
in Enceclopedia of Medical Devices and Instrumentation, Second Edition, 2006 John Wiley & Sons, Inc.
https://onlinelibrary.wiley.com/doi/10.1002/0471732877.emd138

6. Congress abstracts:

Kleef R, Nagy R, Bacher V, Bakacs T, Lausch T, McKee D, Moss R, Bojar H, Thoennissen N:
Low-dose checkpoint inhibitors with hyperthermia and IL-2 are safe and effective in stage IV cancer with unfavourable immunological profile (MSI low, PD-L1 under 1%, TMB low) – A single-institution experience from 2015 to 2020
The 7th leading International Cancer Immunotherapy Conference in Europe, 2–4 October 2020, virtual conference, P08.01
J Immunother Cancer 2020;8(Suppl 2):A1–A67
PDF Download

Kleef R, Nagy R, Bohdjalian A, Bacher V, Kekic A, Kekic S, McKee D, Bojar H, Moss R:
Complete response of stage IV pancreatic cancer combining dose adapte d checkpoint inhibitors with interleukin 2 (IL 2) and fever range hyperthermia
Poster - CRI-CIMT-EATI-AACR INTERNATIONAL CANCER IMMUNOTHERAPY CONFERENCE, 25-28 Sep 2019, Paris
PDF Download

Kleef R:
Coley remembered – back to the roots. Fevertherapy of cancer in the light of modern immunology.
Abstract - Medizinische Woche Baden-Baden 03.10.-03.11.2019
PDF Download

Kleef R, Nagy R, Bohdjalian A, Bacher V, Wychera A, Kekic S, McKee D, Bojar H, Moss R:
Complete response of stage IV pancreatic cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia
The 6th Leading International Cancer Immunotherapy Conference in Europe / European Journal of Cancer 110 (2019) S22
https://www.ejcancer.com/article/S0959-8049(19)30099-1/fulltext

Wey S:
14 years fever-range whole body hyperthermia in adjuvant recurrence prophylaxis of breast cancer.
ESHO 2018 Berlin, P 12
https://link.springer.com/content/pdf/10.1007%2Fs00066-018-1295-1.pdf , p. 495
 

Wey S:
Secondary and tertiary recurrence prevention with fever range whole-body hyperthermia in (metastatic) malignant melanoma.
ESHO 2018 Berlin, P 13
https://link.springer.com/content/pdf/10.1007%2Fs00066-018-1295-1.pdf , p. 496
 

Kleef R, Bojar H, Moss R, Stix A, Bohdjalian A, Bacher V, Nagy R, McKee D:
Exogenous and endogenous hyperthermia combining lowdose checkpoint inhibitors with interleukin-2 (IL-2) and fever range whole body and local regional hyperthermia in stage IV cancer.
ESHO 2018 Berlin, P 35
https://link.springer.com/content/pdf/10.1007%2Fs00066-018-1295-1.pdf , p. 504
 

Pinto J, Ferreira A, Ferreira C, Cruz A, Pinto M:
Fever-range whole body hyperthermia with concomitant capecitabine in third line therapy for BRCA mutated metastatic breast cancer.
ESHO 2018 Berlin, P 38
https://link.springer.com/content/pdf/10.1007%2Fs00066-018-1295-1.pdf , p. 506
 

Kleef R, Bohdjalian A, McKee D, Moss RW:
Complete response of stage IIIB esophageal cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia.
4th ImmunoTherapy of Cancer Conference, Prague, Czech Republic. 20–22 March 2017, A39
J Immunotherapy Cancer 5, 12 (2017).
https://jitc.biomedcentral.com/articles/10.1186/s40425-017-0219-4

Kleef R:
Low-dose checkpoint inhibitor therapy with interleukin-2 (IL-2) and fever range hyperthermia in stage IV cancer: a retrospective analysis with single case presentations
ESHO 2017 21-23 June Athens, Greece, Abstracts OP-10
ESHO2017 ABSTRACTBOOK , p. 65
 

Kleef R, Bohdjalian A, McKee D, Moss RW:
Complete response of stage IIIB esophageal cancer combining low-dose checkpoint inhibitors with interleukin-2 (IL-2) and fever range hyperthermia.
Journal for ImmunoTherapy of Cancer 2017, 5(Suppl 1):12 DOI 10.1186/s40425-017-0219-4
https://jitc.biomedcentral.com/track/pdf/10.1186/s40425-017-0219-4 , A39, p.15
 

Kleef R, Moss RW, Szasz AM, Bohdjalian A, Bakacs T:
Near complete remission of pulmonary metastases in triple negative breast cancer (TNBC) using low-dose immune checkpoint (IC) inhibitors with high dose (HD) interleukin-2 (IL-2) and fever range hyperthermia
EJC, Vol55, Suppl.1, March 2016; 3rd Immunotherapy of Cancer Conference 21–23 March, 2016, Munich/Germany
http://meetinglibrary.asco.org/record/127689/abstract

1. Clinical studies using heckel WBH systems

Changlin Zhao , Congqi Dai, Xiaoyin Chen:
Whole body hyperthermia combined with intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer
Int.J.Hyperthermia, December 2012; 28(8): 735-741
https://www.ncbi.nlm.nih.gov/pubmed/23113543

Douwes F, Bogovic J, Douwes O, Migeod F, Grote C:
Whole body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer
Int J Clin Oncol. 2004 Apr;9(2):85-91
https://www.ncbi.nlm.nih.gov/pubmed/15108039

Gaworek J, Mayer CT:
Systemische Ganzkörperhyperthermie in der Onkologie: Tödliche Hitze für Tumorzellen
[Systemic whole body hyperthermia in oncology: fatal heat for tumor cells].
Pflege Z. 2003 Jan;56(1):15-8
[ARTICLE IN GERMAN] http://www.daryan.de/admin/download/file_150.pdf

Reichel M, Scheeren TWL, Douwes O, Konrad RM:
Tiefe intravenöse Analgosedierung zur extremen Ganzkörperhyperthermie in Kombination mit Chemotherapie
[Deep intravenous analgosedation for extreme whole-body hyperthermia in combination with chemotherapy]
Forum Komplementäre Onkologie & Forum Immunologie, 3/2004, 4-8
[ARTICLE IN GERMAN] OPEN ACCESS http://www.rug.nl/research/portal/files/38850130/2004_Tiefe_intravenoese_Analgosedierung_zur_extremen_Ganzkoerperhyperthermie_in_Kombination_mit_Chemotherapie.pdf

1. Clinical studies using heckel WBH systems

Flux MC, Smith DG, Allen JJB, Mehl MR, Medrano A, Begay TK, Middlemist BH, Marquart BM, Cole SP, Sauder CJ, Lowry CA, Raison CL:
Association of plasma cytokines and antidepressant response following mild-intensity whole-body hyperthermia in major depressive disorder    
Transl Psychiatry. 2023 Apr 21;13(1):132.
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121589/

Janssen CW, Lowry CA:Janssen CW, Lowry CA, Mehl MR, Allen JJ, Kelly KL, Gartner DE, Medrano A, Begay TK, Rentscher K, White JJ, Fridman A, Roberts LJ, Robbins ML, Hanusch KU, Cole SP, Raison CL:
Whole-Body Hyperthermia for the Treatment of Major Depressive Disorder: A Randomized Clinical Trial    
JAMA Psychiatry. 2016 Aug 1;73(8):789-95
OPEN ACCESS: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2521478

Raison CL, Janssen CW, Lowry CA:
Hyperthermia for Major Depressive Disorder?-Reply
JAMA Psychiatry. 2016 Oct 1;73(10):1096-1097
https://www.ncbi.nlm.nih.gov/pubmed/27627698
 

Hanusch KU, Janssen CH, Billheimer D, Jenkins I, Spurgeon E, Lowry CA, Raison CL:
Whole-Body Hyperthermia for the Treatment of Major Depression: Associations With Thermoregulatory Cooling
Am J Psychiatry 170:7, July 2013
https://www.ncbi.nlm.nih.gov/pubmed/23820835

2. Clinical studies using other WBH techniques

Naumann J, Grebe J, Kaifel S, Weinert T, Sadaghiani C, Huber R:
Effects of hyperthermic baths on depression, sleep and heart rate variability in patients with depressive disorder: a randomized clinical pilot trial
BMC Complement Altern Med. 2017; 17: 172
OPEN ACCESS: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371197/

3. Reviews, overviews, book chapters

Knobel A, Hanusch K, Auen N, Rübener F, Fischer S, Borzim C, Heinz A, Schäfer M:
Whole-Body Hyperthermia (WBH) in Psychiatry
In: Water-filtered Infrared A (wIRA) Irradiation (Ed.: P. Vaupel), pp. 155-164. Springer Nature Switzerland, Cham. DOI: 10.1007/978-3-030-92880-3_12
OPEN ACCESS https://link.springer.com/content/pdf/10.1007%2F978-3-030-92880-3_12
 

Hanusch KU, Janssen CW:
The impact of wholebody hyperthermia interventions on mood and depression – are we ready for recommendations for clinical application?
International Journal of Hyperthermia, 2019, 36:1, 573-581, DOI: 10.1080/02656736.2019.1612103
OPEN ACCESS https://tandfonline.com/doi/full/10.1080/02656736.2019.1612103

Woesner ME:
What is old is new again: The use of whole-body hyperthermia for depression recalls the medicinal uses of hyperthermia, fever therapy, and hydrotherapy.
Curr Neurobiol 2019; 10(2): 56-66.
OPEN ACCESS http://currentneurobiology.org/neurobiology/what-is-old-is-new-again-the-use-of-wholebody-hyperthermia-for-depression-recalls-the-medicinal-uses-of-hyperthermia-fever-therapy-and-hydrotherapy.pdf
 

Hanusch KU, Janssen CH:
Die Ganzkörperhyperthermie in der Psychiatrie - Eine historische Analyse
[ARTICLE IN GERMAN] Die Naturheilkunde 02/2013

Hanusch KU:
“Antidepressive” Effect through Heat Therapy - Influence of the psychical condition of depressive patients through passive whole-body hyperthermia.
MASTER'S THESIS, Clinical Psychoneuroimmunology, University of Girona (UdG) / University of Graz, Uni4Life, Nov. 2012
https://www.researchgate.net/profile/Kay_U_Hanusch/publication/255685750_Antidepressive_Effect_through_Heat_Therapy/links/00b7d520286fe9f1c8000000/Antidepressive-Effect-through-Heat-Therapy.pdf

Janssen C, Hanusch KU:
Passive Ganzkörperhyperthermie bei Depressionen
[ARTICLE IN GERMAN] Die Naturheilkunde 05/2011

1. Clinical studies using heckel WBH systems

Douwes F:
Komplextherapie der chronischen Borreliose (Lyme Disease) - Ein neuer Therapieansatz: die Antibiotika augmentierte Thermoeradikation (AAT).
OM & Ernährung 2018 / Nr. 164 [Article in German]
https://www.omundernaehrung.com/ausgaben/nr-164.html

Douwes F:
The successful antibiotic augmented thermal eradication of chronic lyme disease.
ESHO 2018 Berlin, P 43
https://link.springer.com/content/pdf/10.1007%2Fs00066-018-1295-1.pdf

Zauner D, Quehenberger F, Hermann J, Dejaco C, Stradner M, Stojakovic T, Angerer H, Rinner B, Graninger WB:
Whole body hyperthermia treatment increases interleukin 10 and toll-like receptor 4 expression in patients with ankylosing spondylitis:A pilot study
Int J Hyperthermia, 2014; 30(6): 393–401
https://www.tandfonline.com/doi/pdf/10.3109/02656736.2014.956810?needAccess=true

Fuchs, Y:
Effekte einer moderaten Infrarot- Ganzkörper- Hyperthermie auf die Akut- Phase Reaktion
Diplomarbeit Medical University of Graz; 2010. pp. 73
[ARTICLE IN GERMAN] OPEN ACCESS: https://online.medunigraz.at/mug_online/wbabs.getDocument?pThesisNr=18419&pAutorNr=59958&pOrgNR=1

Hanusch KU, Janssen CH, Gluch A:
Passive Infrarot-A-Ganzkörperhyperthermie (Heckelbett) bei rheumatischen Erkrankungen
Schweiz Z Ganzheitsmed 2011;23:327–330
[ARTICLE IN GERMAN] OPEN ACCESS https://www.karger.com/Article/PDF/334700

2. Pre-clinical studies

Lee CT, Kokolus KM, Leigh ND, Capitano M, Hylander BL, Repasky EA:
Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis.
PLoS One. 2015 Mar 20;10(3):e0120327
OPEN ACCESS https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368208/

Reisinger E, Wendelin I, Gasser R, Halwachs G, Wilders-Truschnig M, Krejs G:
Antibiotics and Increased Temperature against Borrelia burgdorferi in Vitro
Scandinavian Journal of Infectious Diseases, Vol.28, 1996, Issue 2, pp. 155-157
http://www.tandfonline.com/doi/abs/10.3109/00365549609049067

Heckel-Reusser S:
Whole-Body Hyperthermia (WBH): Historical Aspects, Current Use, and Future Perspectives.
In: Water-filtered Infrared A (wIRA) Irradiation (Ed.: P. Vaupel), pp. 143-154. Springer Nature Switzerland, Cham. DOI: 10.1007/978-3-030-92880-3_11
OPEN ACCESS https://link.springer.com/content/pdf/10.1007%2F978-3-030-92880-3_11

Kok HP, Cressman ENK, Ceelen W, Brace CL, Ivkov R, Grüll H, Ter Haar G, Wust P, Crezee J:
Heating Technology for Malignant Tumors: A Review.
Int J Hyperthermia. 2020;37(1):711-741. doi: 10.1080/02656736.2020.1779357
OPEN ACCESS: https://www.tandfonline.com/doi/full/10.1080/02656736.2020.177935

Evans SS, Repasky EA, Fischer DT:
Fever and the thermal regulation of immunity: the immune system feels the heat.
Nat Rev Immunol. 2015 Jun; 15(6)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786079/

Kleef R:
Hyperthermie und Entgiftung
OM & Ernährung 2011 / Nr.135
[ARTICLE IN GERMAN] http://www.omundernaehrung.com/ausgaben/nr-135.html

Heckel M, Dickreiter B:
Ganzkörperhyperthermie – Kontrollierte Erhöhung der Körpertemperatur zu therapeutischen Zwecken
Natur-Heilkunde Journal, 10+11/2007